Additional file 2: of Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis

The list of extracted 20 features for EGFR mutant-gefitinib and -erlotinib complexes. The first column is the mutation name. The last column is the response level to gefitinib or erlotinib. The first row is the index of features. (XLSX 27Â kb)